What is a Malaria pf/pan Test Kit used for?

Introduction

Malaria is a life-threatening disease caused by parasites transmitted to humans through the bites of infected female Anopheles mosquitoes. Rapid diagnosis and treatment are crucial in managing and reducing the morbidity and mortality associated with malaria. The Malaria pf/pan Test Kit is a vital tool in the diagnostic arsenal against this disease.

Understanding Malaria

Malaria is caused by Plasmodium parasites, which include several species: P. falciparum, P. vivax, P. ovale, and P. malariae. Among these, P. falciparum is the most deadly. Between 2015 and 2020, there were approximately 229 million malaria cases globally, with an estimated 409,000 deaths in 2019 alone.

Malaria pf/pan Test Kit

Functionality

The Malaria pf/pan Test Kit is used for rapid detection and differentiation between P. falciparum and other Plasmodium species. The test operates on the principle of immunochromatography, where antibodies specific to various Plasmodium antigens (HRP2 for P. falciparum and pLDH for pan-Plasmodium detection) are used.

Technical Specifications

• Sensitivity: Greater than 95% for P. falciparum.
• Specificity: Greater than 90% for non-falciparum species.
• Time to Result: 15 – 20 minutes.
• Storage Conditions: Store at 2-30°C, avoid direct sunlight.

QL Biotech Company Solutions

QL Biotech offers an advanced Malaria pf/pan Test Kit that provides enhanced sensitivity and specificity through optimized monoclonal antibodies and a robust platform design.

• Utilizes proprietary antigen-capture technology for improved accuracy.
• Validated in regions with varying malaria prevalence.
• Supports both point-of-care settings and laboratory environments.

Numerical Analysis

Case Reduction Potential

In field trials, the utilization of pf/pan test kits in conjunction with therapeutic interventions reduced malaria cases by approximately 35% in endemic regions over a 12-month period.

Economic Impact

Providing rapid diagnostic kits resulted in a decrease in treatment costs by 20% due to reduced malaria misdiagnosis and inappropriate treatment strategies.

References

• World Health Organization. World Malaria Report 2020. WHO Library Cataloguing-in-Publication Data.
• John, D. & Smith, A. Evaluation of a Rapid Diagnostic Test for Malaria in African Children. Journal of Clinical Microbiology, 2020.
• QL Biotech Company. Malaria Diagnostic Solutions, 2023.